Bradley L Campbell Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Bradley L Campbell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bradley L Campbell. Bradley L Campbell is in PROGENICS PHARMACEUTICALS INC ($PGNX) and Director in PROGENICS PHARMACEUTICALS INC ($PGNX) and Chief Business Officer in AMICUS THERAPEUTICS INC ($FOLD) and Chief Operating Officer in AMICUS THERAPEUTICS INC ($FOLD) and SVP, Business Operations in AMICUS THERAPEUTICS INC ($FOLD) and VP, Business Development in AMICUS THERAPEUTICS INC ($FOLD) and VP, Business Operations in AMICUS THERAPEUTICS INC ($FOLD).
Latest Insider Trading Transactions of Bradley L Campbell
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 4.38 | 3,891 | 17,043 | 66,088 | |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.45 | 6,623 | 42,718 | 0 | |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 3.53 | 12,345 | 43,578 | 65,655 | |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.52 | 10,653 | 26,846 | 0 | |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.94 | 15,223 | 44,756 | 74,777 | |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.45 | 24,375 | 59,719 | 65,625 | |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.01 | 10,514 | 105,207 | 457,268 | 467.8 K to 457.3 K (-2.25 %) |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 4.38 | 3,891 | 17,043 | 467,782 | 463.9 K to 467.8 K (+0.84 %) |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.45 | 6,623 | 42,718 | 463,891 | 457.3 K to 463.9 K (+1.45 %) |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 10.08 | 17,350 | 174,888 | 457,268 | 474.6 K to 457.3 K (-3.66 %) |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 3.53 | 12,345 | 43,578 | 474,618 | 462.3 K to 474.6 K (+2.67 %) |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 2.52 | 10,653 | 26,846 | 462,273 | 451.6 K to 462.3 K (+2.36 %) |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 2.94 | 15,223 | 44,756 | 451,620 | 436.4 K to 451.6 K (+3.49 %) |
| Jun 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 2.45 | 24,375 | 59,719 | 436,397 | 412 K to 436.4 K (+5.92 %) |
| May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.45 | 10,514 | 67,815 | 6,623 | |
| May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.27 | 10,514 | 107,970 | 412,022 | 422.5 K to 412 K (-2.49 %) |
| May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.45 | 10,514 | 67,815 | 422,536 | 412 K to 422.5 K (+2.55 %) |
| Apr 08 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 33,165 | 0 | 412,022 | 378.9 K to 412 K (+8.75 %) |
| Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 21.84 | 14,463 | 315,800 | 378,857 | 393.3 K to 378.9 K (-3.68 %) |
| Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 29,367 | 0 | 393,320 | 364 K to 393.3 K (+8.07 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 21.78 | 92,792 | 2,021,010 | 92,792 | |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.45 | 10,514 | 67,815 | 48,679 | |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 57,620 | 0 | 363,953 | 306.3 K to 364 K (+18.81 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 22.17 | 10,514 | 233,125 | 306,333 | 316.8 K to 306.3 K (-3.32 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.45 | 10,514 | 67,815 | 316,847 | 306.3 K to 316.8 K (+3.43 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 23.09 | 13,974 | 322,660 | 306,333 | 320.3 K to 306.3 K (-4.36 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 23.09 | 26,908 | 621,306 | 320,307 | 347.2 K to 320.3 K (-7.75 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 23.09 | 7,617 | 175,877 | 347,215 | 354.8 K to 347.2 K (-2.15 %) |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 4.38 | 10,021 | 43,892 | 69,979 | |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.45 | 10,807 | 69,705 | 59,193 | |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 23.86 | 4,760 | 113,574 | 354,832 | 359.6 K to 354.8 K (-1.32 %) |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 4.38 | 10,021 | 43,892 | 359,592 | 349.6 K to 359.6 K (+2.87 %) |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.45 | 10,807 | 69,705 | 349,571 | 338.8 K to 349.6 K (+3.19 %) |
| Sep 30 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.52 | 24,782 | 62,451 | 60,218 | |
| Sep 30 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 13.89 | 24,782 | 344,205 | 338,764 | 363.5 K to 338.8 K (-6.82 %) |
| Sep 30 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 2.52 | 24,782 | 62,451 | 363,546 | 338.8 K to 363.5 K (+7.32 %) |
| Aug 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.06 | 10,000 | 60,600 | 0 | |
| Aug 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 14.78 | 10,000 | 147,779 | 338,764 | 348.8 K to 338.8 K (-2.87 %) |
| Aug 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.06 | 10,000 | 60,600 | 348,764 | 338.8 K to 348.8 K (+2.95 %) |
| Jul 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.06 | 2,500 | 15,150 | 10,000 | |
| Jul 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 16.01 | 2,500 | 40,025 | 338,764 | 341.3 K to 338.8 K (-0.73 %) |
| Jul 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.06 | 2,500 | 15,150 | 341,264 | 338.8 K to 341.3 K (+0.74 %) |
| Jul 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.06 | 12,500 | 75,750 | 12,500 | |
| Jul 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 15.47 | 12,500 | 193,384 | 338,764 | 351.3 K to 338.8 K (-3.56 %) |
| Jul 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.06 | 12,500 | 75,750 | 351,264 | 338.8 K to 351.3 K (+3.69 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 4.89 | 28,000 | 136,920 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Sell | D | 0.00 | 12,000 | 0 | 0 | 12 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 4.89 | 28,000 | 136,920 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Sell | D | 0.00 | 12,000 | 0 | 0 | 12 K to 0 (-100.00 %) |
| Jun 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 11.14 | 9,089 | 101,251 | 338,764 | 347.9 K to 338.8 K (-2.61 %) |
| Jun 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.06 | 2,500 | 15,150 | 25,000 | |
| Jun 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.06 | 10,000 | 60,600 | 27,500 | |
| Jun 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 13.01 | 2,500 | 32,525 | 347,853 | 350.4 K to 347.9 K (-0.71 %) |
| Jun 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.06 | 2,500 | 15,150 | 350,353 | 347.9 K to 350.4 K (+0.72 %) |
| Jun 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 12.66 | 17,502 | 221,495 | 347,853 | 365.4 K to 347.9 K (-4.79 %) |
| Jun 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.06 | 10,000 | 60,600 | 365,355 | 355.4 K to 365.4 K (+2.81 %) |
| May 28 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.06 | 2,500 | 15,150 | 37,500 | |
| May 28 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 13.01 | 2,500 | 32,525 | 355,355 | 357.9 K to 355.4 K (-0.70 %) |
| May 28 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.06 | 2,500 | 15,150 | 357,855 | 355.4 K to 357.9 K (+0.70 %) |
| May 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.06 | 10,000 | 60,600 | 40,000 | |
| May 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 11.33 | 17,503 | 198,239 | 355,355 | 372.9 K to 355.4 K (-4.69 %) |
| May 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.06 | 10,000 | 60,600 | 372,858 | 362.9 K to 372.9 K (+2.76 %) |
| Apr 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.06 | 2,500 | 15,150 | 50,000 | |
| Apr 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.12 | 2,500 | 25,300 | 362,858 | 365.4 K to 362.9 K (-0.68 %) |
| Apr 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.06 | 2,500 | 15,150 | 365,358 | 362.9 K to 365.4 K (+0.69 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 6.06 | 7,500 | 45,450 | 52,500 | |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 14,847 | 0 | 362,858 | 348 K to 362.9 K (+4.27 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 9.09 | 15,003 | 136,310 | 348,011 | 363 K to 348 K (-4.13 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 6.06 | 7,500 | 45,450 | 363,014 | 355.5 K to 363 K (+2.11 %) |
| Mar 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 2,500 | 14,900 | 0 | |
| Mar 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.01 | 2,500 | 25,025 | 355,514 | 358 K to 355.5 K (-0.70 %) |
| Mar 09 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 2,500 | 14,900 | 358,014 | 355.5 K to 358 K (+0.70 %) |
| Mar 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 7,500 | 44,700 | 2,500 | |
| Mar 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 9.09 | 15,003 | 136,445 | 355,514 | 370.5 K to 355.5 K (-4.05 %) |
| Mar 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 7,500 | 44,700 | 370,517 | 363 K to 370.5 K (+2.07 %) |
| Feb 07 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 2,500 | 14,900 | 10,000 | |
| Feb 07 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.01 | 2,500 | 25,025 | 363,017 | 365.5 K to 363 K (-0.68 %) |
| Feb 07 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 2,500 | 14,900 | 365,517 | 363 K to 365.5 K (+0.69 %) |
| Feb 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 7,500 | 44,700 | 12,500 | |
| Feb 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 8.91 | 15,003 | 133,626 | 363,017 | 378 K to 363 K (-3.97 %) |
| Feb 04 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 7,500 | 44,700 | 378,020 | 370.5 K to 378 K (+2.02 %) |
| Jan 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.35 | 5,064 | 52,388 | 370,520 | 375.6 K to 370.5 K (-1.35 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.46 | 29,492 | 278,994 | 375,584 | 405.1 K to 375.6 K (-7.28 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 59,881 | 0 | 405,076 | 345.2 K to 405.1 K (+17.35 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.46 | 29,492 | 278,994 | 375,584 | 405.1 K to 375.6 K (-7.28 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 59,881 | 0 | 405,076 | 345.2 K to 405.1 K (+17.35 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 2,500 | 14,900 | 20,000 | |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.01 | 2,500 | 25,025 | 345,195 | 347.7 K to 345.2 K (-0.72 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 2,500 | 14,900 | 347,695 | 345.2 K to 347.7 K (+0.72 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.18 | 13,973 | 128,272 | 345,195 | 359.2 K to 345.2 K (-3.89 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.55 | 12,161 | 116,138 | 359,168 | 371.3 K to 359.2 K (-3.27 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 5.96 | 7,500 | 44,700 | 22,500 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 9.55 | 188,257 | 1,797,854 | 188,257 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 9.61 | 7,500 | 72,039 | 359,140 | 366.6 K to 359.1 K (-2.05 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 5.96 | 7,500 | 44,700 | 366,640 | 359.1 K to 366.6 K (+2.09 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 9.56 | 14,627 | 139,850 | 359,140 | 373.8 K to 359.1 K (-3.91 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 119,780 | 0 | 373,767 | 254 K to 373.8 K (+47.16 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.74 | 15,556 | 151,515 | 253,987 | 269.5 K to 254 K (-5.77 %) |
| Jul 15 2019 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Option Exercise | A | 5.74 | 25,000 | 143,500 | 25,000 | ||
| Jul 08 2019 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Option Exercise | M | 4.89 | 12,000 | 58,680 | 0 | ||
| Jul 08 2019 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Buy | M | 4.89 | 12,000 | 58,680 | 12,000 | 0 to 12 K | |
| Apr 15 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 30,183 | 0 | 269,543 | 239.4 K to 269.5 K (+12.61 %) |
| Jan 24 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 10.36 | 36,000 | 372,960 | 0 | |
| Jan 24 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 11.81 | 36,000 | 425,135 | 239,360 | 275.4 K to 239.4 K (-13.07 %) |
| Jan 24 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 10.36 | 36,000 | 372,960 | 275,360 | 239.4 K to 275.4 K (+15.04 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 10.04 | 151,515 | 1,521,211 | 151,515 | |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 10.33 | 13,518 | 139,641 | 239,360 | 252.9 K to 239.4 K (-5.35 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 98,778 | 0 | 252,878 | 154.1 K to 252.9 K (+64.10 %) |
| Jun 14 2018 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Option Exercise | A | 8.99 | 25,000 | 224,750 | 25,000 | ||
| Jan 24 2018 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 10.21 | 32,500 | 331,825 | 0 | |
| Jan 24 2018 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 15.92 | 32,500 | 517,371 | 154,100 | 186.6 K to 154.1 K (-17.42 %) |
| Jan 24 2018 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 10.21 | 32,500 | 331,825 | 186,600 | 154.1 K to 186.6 K (+21.09 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 15.67 | 56,329 | 882,675 | 56,329 | |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 15.67 | 9,345 | 146,436 | 154,100 | 163.4 K to 154.1 K (-5.72 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 38,973 | 0 | 163,445 | 124.5 K to 163.4 K (+31.31 %) |
| Jun 19 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 8.79 | 3,003 | 26,396 | 124,472 | 127.5 K to 124.5 K (-2.36 %) |
| Jun 15 2017 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Option Exercise | A | 6.95 | 20,000 | 139,000 | 20,000 | ||
| Jun 15 2017 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Option Exercise | A | 6.95 | 20,000 | 139,000 | 20,000 | ||
| Mar 03 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 8.00 | 49,050 | 392,400 | 127,475 | 176.5 K to 127.5 K (-27.79 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 5.13 | 103,578 | 531,355 | 103,578 | |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 5.13 | 50,950 | 261,374 | 176,525 | 227.5 K to 176.5 K (-22.40 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 0.00 | 100,000 | 0 | 227,475 | 127.5 K to 227.5 K (+78.45 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 74,525 | 0 | 127,475 | 53 K to 127.5 K (+140.75 %) |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 6.10 | 75,000 | 457,500 | 75,000 | |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 25,000 | 0 | 52,950 | 28 K to 53 K (+89.45 %) |
| Jun 09 2016 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Option Exercise | A | 4.89 | 40,000 | 195,600 | 40,000 | ||
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 9.03 | 100,000 | 903,000 | 100,000 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 0.00 | 50,000 | 0 | 100,000 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.03 | 18,625 | 168,184 | 37,950 | 56.6 K to 38 K (-32.92 %) |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 0.00 | 50,000 | 0 | 56,575 | 6.6 K to 56.6 K (+760.46 %) |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.81 | 417 | 1,172 | 0 | |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 4.16 | 12,584 | 52,349 | 0 | |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 16.78 | 13,001 | 218,206 | 156,575 | 169.6 K to 156.6 K (-7.67 %) |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 16.78 | 13,001 | 218,206 | 169,576 | 156.6 K to 169.6 K (+8.30 %) |
| Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.81 | 416 | 1,169 | 19,167 | |
| Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 4.16 | 12,583 | 52,345 | 12,584 | |
| Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 13.26 | 13,000 | 172,424 | 156,575 | 169.6 K to 156.6 K (-7.67 %) |
| Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 13.26 | 417 | 5,531 | 169,575 | 169.2 K to 169.6 K (+0.25 %) |
| Jun 23 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 13.26 | 12,583 | 166,893 | 169,158 | 156.6 K to 169.2 K (+8.04 %) |
| Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 12.28 | 100,000 | 1,228,000 | 100,000 | |
| May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 0.00 | 50,000 | 0 | 150,000 | |
| May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 10.84 | 24,800 | 268,810 | 6,575 | 31.4 K to 6.6 K (-79.04 %) |
| May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 10.80 | 18,625 | 201,150 | 31,375 | 50 K to 31.4 K (-37.25 %) |